CITIGROUP INC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$19
-88.2%
149
-90.4%
0.00%
Q4 2022$1611,559
-47.3%
0.00%
Q3 2022$0
-100.0%
2,960
-77.4%
0.00%
Q2 2022$12,000
+33.3%
13,118
+82.1%
0.00%
Q1 2022$9,000
-98.9%
7,202
-98.3%
0.00%
Q4 2021$804,000
+67.5%
412,537
+135.7%
0.00%
Q3 2021$480,000
+1555.2%
175,052
+1822.4%
0.00%
Q2 2021$29,000
-73.9%
9,106
-82.6%
0.00%
Q1 2021$111,00052,2600.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders